The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Recruiting

Trial locations(21 sites)

United States

Arrhythmia Institute at Grandview, Birmingham, Alabama

Mobile Cardiology Associates, Mobile, Alabama

Community Memorial Health System, Ventura, California

Medical City - HCA, Aurora, Colorado

Naples Community Hospital, Naples, Florida